Riskpilot← Back to searchSign inGet full accessFädoktorn Gotland AB
ABActiveOrg 5593051898Kantzargatan 9Veterinary activities · NACE 7500Est. 20212 employees
Revenue 2024
SEK 1,8M
+2% vs 2023
EBITDA margin
11.0%
-47% vs 2023
Equity ratio
41.3%
Financial strength
Net profit 2024
SEK 99K
-27% vs 2023
| Revenue | SEK 1,8M | +2% |
| EBITDA | SEK 197K | -47% |
| Net profit | SEK 99K | -27% |
| Total assets | SEK 1M | +15% |
| Equity | SEK 430K | +30% |
| Employees | 2 | — |
Legal name
Fädoktorn Gotland AB
Org number
5593051898
Legal form
Aktiebolag
NACE code
7500 · Veterinary activities
Founded
3 mars 2021
Share capital
SEK 25 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Ambulerande veterinärverksamhet, smådjursmottagning samt därmed förenlig verksamhet.
Address
Kantzargatan 9
Email
info@fadoktorn.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 846 | 1 470 | 1 769 | 1 798 |
| Staff expenses | — | −759 | −813 | −1 007 |
| EBITDA | 152 | 237 | 373 | 197 |
| Depreciation & amort. | −23 | −58 | −72 | −75 |
| EBIT | 129 | 179 | 301 | 123 |
| Net financials | −4 | −19 | −13 | −3 |
| Profit before tax | 35 | 160 | 173 | 126 |
| Tax | −8 | −19 | −36 | −26 |
| Net profit | 27 | 141 | 137 | 99 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 855 | 959 | 906 | 1 042 |
| Equity | 52 | 194 | 331 | 430 |
| Long-term debt | 341 | 323 | 146 | 162 |
| Short-term debt | 372 | 353 | 225 | 252 |
| Total debt | 713 | 676 | 371 | 414 |
EBITDA margin
11.0%
This company
15.8%
Market median
-30% vs market
20212024
Equity ratio
41.3%
This company
38.2%
Market median
+8% vs market
20212024
Return on equity
23.1%
This company
18.4%
Market median
+26% vs market
20212024
Net profit margin
5.5%
This company
8.1%
Market median
-32% vs market
20212024
Asset turnover
1.73×
This company
1.12×
Market median
+54% vs market
20212024
Debt / equity
1.42×
This company
0.62×
Market median
-129% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-03-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MK Chief Executive Officer | Chief Executive Officer | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2025 | |
| Chairman | 2025 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Fädoktorn Gotland AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maria Kristin Gustafsson | Chief Executive Officer | 0 companies |
| Kristian Lars Eric Gustafsson | Deputy Board Member | 0 companies |
| Anna Theresia Duse | Chairman | 0 companies |
| Karl Daniel Patrik Duse | Deputy Board Member | 0 companies |